A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Oct 2014
At a glance
- Drugs PF 6372865 (Primary)
- Indications Pain
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 23 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Sep 2014 Planned End Date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 08 Sep 2014 Planned primary completion date changed from 1 Aug 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.